Published in Neurology on September 14, 2005
Association between phosphodiesterase 4D gene and ischaemic stroke. J Neurol Neurosurg Psychiatry (2006) 1.11
Phosphodiesterase 4D polymorphisms and the risk of cerebral infarction in a biracial population: the Stroke Prevention in Young Women Study. Hum Mol Genet (2006) 1.06
Phosphodiesterase 4D and 5-lipoxygenase activating protein genes and risk of ischemic stroke in Sardinians. Eur J Hum Genet (2009) 0.97
Structural genomic variation in ischemic stroke. Neurogenetics (2008) 0.93
Meta-analysis of association between variation in the PDE4D gene and ischemic cerebral infarction risk in Asian populations. Neurogenetics (2010) 0.91
A large-sample assessment of possible association between ischaemic stroke and rs12188950 in the PDE4D gene. Eur J Hum Genet (2012) 0.85
Phosphodiesterase 4D gene and risk of noncardiogenic ischemic stroke in a Korean population. J Korean Med Sci (2009) 0.83
PDE4D and stroke: a real advance or a case of the Emperor's new clothes? Stroke (2006) 0.80
Genetics of atherothrombotic and lacunar stroke. Circ Cardiovasc Genet (2009) 0.80
Genetics of Vascular Dementia. Minerva Psichiatr (2010) 0.75
The Impact of Evolutionary Driving Forces on Human Complex Diseases: A Population Genetics Approach. Scientifica (Cairo) (2016) 0.75
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke (1993) 29.81
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24
Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet (2006) 10.72
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med (2001) 7.85
A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med (1996) 7.66
Absence of expression of the FMR-1 gene in fragile X syndrome. Cell (1991) 7.04
The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med (1995) 6.73
[TIA... an aspirin?]. Ned Tijdschr Geneeskd (1995) 5.21
Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci U S A (1997) 4.73
Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology (1994) 3.75
A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nat Genet (2000) 3.63
A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat Genet (1993) 3.58
Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. Lancet (2005) 3.46
Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet (1998) 3.26
Intracerebral hematomas during anticoagulant treatment. Stroke (1990) 2.97
Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome. Neuron (2005) 2.82
Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia (1997) 2.82
Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet (1998) 2.82
Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology (2005) 2.69
Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol (1991) 2.63
Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol (1998) 2.53
ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology (2007) 2.51
Primary structure and processing of lysosomal alpha-glucosidase; homology with the intestinal sucrase-isomaltase complex. EMBO J (1988) 2.44
Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet (1992) 2.40
Diffusion-weighted magnetic resonance imaging in acute stroke. Stroke (1998) 2.40
Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol (1991) 2.36
Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature (1993) 2.36
Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol (1998) 2.31
Genome-wide association scan for five major dimensions of personality. Mol Psychiatry (2008) 2.29
Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group. Am J Hum Genet (1997) 2.27
Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet (1998) 2.26
FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J Med Genet (1999) 2.23
Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE. Nat Genet (1994) 2.19
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology (2006) 2.19
Distinct genetic forms of frontotemporal dementia. Neurology (2008) 2.15
Cognitive correlates of ventricular enlargement and cerebral white matter lesions on magnetic resonance imaging. The Rotterdam Study. Stroke (1994) 2.14
Thunderclap headache as first symptom of cerebral venous sinus thrombosis. CVST Study Group. Lancet (1996) 2.14
[Familial forms of fronto-temporal dementia]. Ned Tijdschr Geneeskd (1995) 2.04
[Effectiveness of endarterectomy for symptomatic stenosis of the internal carotid artery; more risk factors important than only the severity of the stenosis]. Ned Tijdschr Geneeskd (2007) 2.04
The fragile X syndrome. J Med Genet (1998) 2.00
Genetic risk of primary open-angle glaucoma. Population-based familial aggregation study. Arch Ophthalmol (1998) 1.98
Meta-analysis of genome-wide association studies for personality. Mol Psychiatry (2010) 1.96
Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain (2004) 1.96
[Thrombolytic therapy of brain infarct: the end of beginning]. Ned Tijdschr Geneeskd (2000) 1.94
Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry (2007) 1.93
ACE polymorphisms. Circ Res (2006) 1.92
Symptomatic carotid artery occlusion. A reappraisal of hemodynamic factors. Stroke (1997) 1.92
[Possible treatments for patients with symptomatic carotid artery stenosis]. Ned Tijdschr Geneeskd (2005) 1.92
DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism. Neurol Sci (2003) 1.90
Deletion loop mutagenesis: a novel method for the construction of point mutations using deletion mutants. Nucleic Acids Res (1982) 1.90
Power of selective genotyping in genetic association analyses of quantitative traits. Behav Genet (2000) 1.89
Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology (2005) 1.88
Potentially lethal bacterial infection associated with varicella zoster virus. BMJ (1996) 1.88
High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am J Hum Genet (1999) 1.87
Octapeptide repeat insertions in the prion protein gene and early onset dementia. J Neurol Neurosurg Psychiatry (2004) 1.87
A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet (2001) 1.83
Ischemic stroke in young adults. Experience in 329 patients enrolled in the Iowa Registry of stroke in young adults. Arch Neurol (1995) 1.83
Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology (2002) 1.82
Incidence of dementia: does gender make a difference? Neurobiol Aging (2001) 1.81
Recurrent ischemia in symptomatic carotid occlusion: prognostic value of hemodynamic factors. Neurology (2000) 1.80
A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter. Hum Mol Genet (1992) 1.80
Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia (2000) 1.80
Sporadic Creutzfeldt-Jakob disease and surgery: a case-control study using community controls. Neurology (2002) 1.78
A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia (2009) 1.76
Familial aggregation in frontotemporal dementia. Neurology (1998) 1.76
A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes (2001) 1.76
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol (2009) 1.76
The Corsi Block-Tapping Task: standardization and normative data. Appl Neuropsychol (2000) 1.74
Characterization of the full fragile X syndrome mutation in fetal gametes. Nat Genet (1997) 1.74
Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol (1999) 1.73
Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse. Exp Cell Res (2000) 1.73
Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36. Am J Hum Genet (2001) 1.71
CGG repeat in the FMR1 gene: size matters. Clin Genet (2011) 1.68
[Creative mathematics with clopidogrel; exaggeration of the preventive effect by manufacturer]. Ned Tijdschr Geneeskd (1999) 1.68
Familial aggregation of parkinsonism in progressive supranuclear palsy. Neurology (2009) 1.68
Clinical and molecular studies in fragile X patients with a Prader-Willi-like phenotype. J Med Genet (1993) 1.68
Risk of cardiac events in atypical transient ischaemic attack or minor stroke. The Dutch TIA Study Group. Lancet (1992) 1.68
Interphysician agreement in the diagnosis of subtypes of acute ischemic stroke: implications for clinical trials. The TOAST Investigators. Neurology (1993) 1.63
Normal phenotype in two brothers with a full FMR1 mutation. Hum Mol Genet (1995) 1.63
Shared genetic factors in migraine and depression: evidence from a genetic isolate. Neurology (2010) 1.61